SIGYN THERAPEUTICS INC (SIGY:OTCMKTS)
$0.036 0.01 (38.4615%)
Analysed SIGYN THERAPEUTICS INC (SIGY:OTCMKTS) News Sources
The Emergence of Blood Purification Devices to Treat Cardiovascular Disease
06-01-2026
yahoo.com
Sigyn Therapeutics Issues Shareholder Update Regarding Potential Merger and Asset Sale Initiatives
13-03-2026
yahoo.com
Scientific American Highlights Scientific Discovery That Supports the Potential Use of CardioDialysis(TM) to Treat Neuroinflammatory Diseases
24-03-2026
yahoo.com
CardioDialysisTM, a Next-Generation Technology to Reduce Major Adverse Cardiovascular Events
27-03-2026
yahoo.com
Sigyn Therapeutics Launches Initiative to Evaluate Emerging Medical Technologies in Former NFL Players at Risk of CTE
02-04-2026
yahoo.com
Q2 Virtual Investor Summit Presentations Now Available On Demand
30-06-2026
yahoo.com
Oragenics Signs Letter of Intent to License CardioDialysis™ Technology from Sigyn Therapeutics to Target TBI-Induced Systemic Inflammation
07-05-2026
yahoo.com
What is the current price of SIGYN THERAPEUTICS INC (SIGY:OTCMKTS)?
The current price of SIGYN THERAPEUTICS INC (SIGY:OTCMKTS) is $0.036.
SIGYN THERAPEUTICS INC (SIGY:OTCMKTS) absolute price change since previous trading day?
The absolute price change of SIGYN THERAPEUTICS INC (SIGY:OTCMKTS) since the previous trading day is $0.01.
SIGYN THERAPEUTICS INC (SIGY:OTCMKTS) percentage price change since previous trading day?
The percentage price change of SIGYN THERAPEUTICS INC (SIGY:OTCMKTS) since the previous trading day is 38.4615%.
What is the most recent average sentiment score for SIGYN THERAPEUTICS INC (SIGY:OTCMKTS)?
The most recent average sentiment score for SIGYN THERAPEUTICS INC (SIGY:OTCMKTS) is 75 out of 100.
What is the most recent average sentiment for SIGYN THERAPEUTICS INC (SIGY:OTCMKTS)?
The most recent sentiment for SIGYN THERAPEUTICS INC (SIGY:OTCMKTS) is .
SEC-8K** Filing Available For SIGYN THERAPEUTICS INC (SIGY:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.